Summary
Updated Aug 31, 2026
Julie Krop files SEC Form 4 reports at Aquestive Therapeutics, Inc. (AQST). 4 SEC Form 4 filings on record going back to 2025, most recently on 24 June 2026. Most recent open-market trade: sold $125K of AQST on 24 June 2026. Lifetime open-market sales: $125K.
Recent Transactions
2Every recent SEC Form 4 transaction Julie Krop has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Julie Krop files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jan Stahlberg - $5.96M of DMAC open-market activity in the last 12 months
- Daniel Barber - $1.65M of AQST open-market activity in the last 12 months
- Cassie Jung - $976K of AQST open-market activity in the last 12 months
- Peter E. Boyd - $337K of AQST open-market activity in the last 12 months
- A. Ernest Toth Jr. - $243K of AQST open-market activity in the last 12 months
- Lori J. Braender - $167K of AQST open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Julie Krop?
Julie Krop is a corporate insider of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Julie Krop submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Julie Krop been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($125K) across all tracked filings.
Where can I see all of Julie Krop's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Julie Krop and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
